Clinical Trial Update: Liver Safety Assessment During Ulipristal Acetate Treatment for Uterine Fibroids (LISA)

View source ↗

Summary

The LISA trial evaluating liver safety of ulipristal acetate for uterine fibroids has been terminated, raising concerns about potential liver injury during trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyoma Uterine

Drugs mentioned

• Esmya (ulipristal acetate)
• Ulipristal acetate (ulipristal acetate)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Leiomyoma, Uterine, Liver Injury | Status: TERMINATED